ImmunityBio, Inc. (IBRX) vs Twist Bioscience Corporation (TWST)

A side-by-side comparison of ImmunityBio, Inc. and Twist Bioscience Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IBRX vs TWST

growth of $100 · dividends reinvested · last 8y
IBRX +371.8% (+21.4%/yr)TWST +1364.3% (+39.9%/yr)TWST compounded faster over this window
05001k2kStart $1002020202220242026$472$1,464
IBRX TWST

IBRX vs TWST: by the numbers

  • •TWST is the larger company ($10.40B vs $10.15B market cap).
  • •Both run net losses; TWST's is the smaller (-31.66% vs -598.56% net margin).
  • •IBRX grew revenue faster over the past five years (202.97% vs 27.77% CAGR).

Metrics side by side

Valuation

MetricIBRXTWST
P/S ratio61.2124.08
P/B ratioN/A23.33

Profitability

MetricIBRXTWST
Gross margin94.63%51.97%
Operating margin-226.00%-31.91%
Net margin-598.56%-31.66%
ROEN/A-30.67%
ROIC-45.63%-24.57%

Growth (annualized)

MetricIBRXTWST
Revenue CAGR (5Y)202.97%27.77%
Total return CAGR (5Y)0.39%15.59%

Frequently asked

Which has grown faster, IBRX or TWST?
Over the past five years, IBRX grew revenue faster — IBRX at a 202.97% CAGR versus TWST at 27.77%.
How have IBRX and TWST total returns compared?
Over the past 5 years, IBRX delivered 0.39% and TWST delivered 15.59% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.